First Manhattan’s PDS Biotechnology PDSB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $20K | Hold |
15,000
| – | – | ﹤0.01% | 696 |
|
|
2025
Q1 | $17.9K | Buy |
+15,000
| New | +$17.9K | ﹤0.01% | 676 |
|
|
2023
Q2 | – | Sell |
-271,576
| Closed | -$1.67M | – | 1527 |
|
|
2023
Q1 | $1.67M | Hold |
271,576
| – | – | 0.01% | 350 |
|
|
2022
Q4 | $3.58M | Hold |
271,576
| – | – | 0.01% | 265 |
|
|
2022
Q3 | $806K | Hold |
271,576
| – | – | ﹤0.01% | 439 |
|
|
2022
Q2 | $991K | Hold |
271,576
| – | – | ﹤0.01% | 420 |
|
|
2022
Q1 | $1.68M | Hold |
271,576
| – | – | 0.01% | 388 |
|
|
2021
Q4 | $2.2M | Buy |
271,576
+75,757
| +39% | +$613K | 0.01% | 332 |
|
|
2021
Q3 | $2.92M | Buy |
195,819
+22,888
| +13% | +$341K | 0.01% | 281 |
|
|
2021
Q2 | $2.17M | Buy |
172,931
+23,864
| +16% | +$299K | 0.01% | 320 |
|
|
2021
Q1 | $678K | Hold |
149,067
| – | – | ﹤0.01% | 475 |
|
|
2020
Q4 | $319K | Hold |
149,067
| – | – | ﹤0.01% | 584 |
|
|
2020
Q3 | $347K | Hold |
149,067
| – | – | ﹤0.01% | 563 |
|
|
2020
Q2 | $299K | Hold |
149,067
| – | – | ﹤0.01% | 577 |
|
|
2020
Q1 | $108K | Buy |
+149,067
| New | +$108K | ﹤0.01% | 725 |
|